own handwriting.
She had created it.
Not the final corrected compound.
An early experimental version.
A version that had never appeared in a published paper, patent application, conference presentation, or public database.
“Where did you get this?” she asked Marcus.
Marcus stared at her.
“Excuse me?”
“That structure.
Where did you get it?”
His eyes hardened.
Donovan turned toward Clare.
“You recognize it?”
“I developed it.”
Julian released her arm.
The atmosphere shifted instantly.
Marcus scoffed.
“This woman was dismissed from her research position after falsifying laboratory results.”
The accusation struck exactly where Marcus intended.
Clare remembered the investigation.
The locked office.
The meeting where three administrators refused to look her in the eye.
The missing files.
The safety committee report claiming that data under her credentials did not match the laboratory’s instrument logs.
She had protested until her voice stopped mattering.
No criminal charges followed, but the professional damage was complete.
Her fellowship disappeared.
Job interviews stopped after reference checks.
A consulting firm rescinded an offer without explanation.
Eventually Clare stopped introducing herself as Doctor Sullivan.
She began waiting tables.
Donovan watched the reaction pass across her face.
“Was he telling the truth?”
Clare looked at Marcus.
“I was accused.
That’s different.”
“Can you prove this formula was yours?”
“Possibly.”
Marcus smiled again.
“Meaning no.”
Clare studied the diagram.
The flaw itself told her something important.
During the original project, she had tested several approaches to increasing thermal resistance.
The structure on Marcus’s tablet came from an early stage, before she discovered that the arrangement degraded under prolonged high-temperature cycling.
She had corrected it three weeks later.
Someone stealing only the finished research would never have chosen this structure.
Someone who obtained her files before the final development might.
“Whoever gave you this copied an incomplete archive,” Clare said.
Marcus’s jaw tightened.
Donovan noticed.
Clare continued.
“This wasn’t my final version.
It was an early trial.
We rejected it after accelerated testing.”
Marcus folded his arms.
“Your recollection from years ago is not evidence.”
“No.
But my laboratory notebook would be.”
“The notebook that supposedly disappeared?”
Clare looked sharply at him.
She had not mentioned that it disappeared.
Neither had Donovan.
Marcus realized his mistake one second too late.
Donovan placed the pen on the table.
“How do you know her notebook disappeared?”
Marcus did not answer immediately.
“It was documented during the internal investigation.”
“Was it?” Clare asked.
She remembered every page of the final report.
The physical notebook had been described only as unavailable for review.
Its disappearance had never been publicly disclosed.
Donovan pushed his chair back.
“Julian, close the door.”
The lock clicked.
Marcus laughed without humor.
“Donovan, don’t be theatrical.
We have a transfer deadline.”
“Why?”
“Because another investor is prepared to take the allocation at midnight.”
Clare looked at the clock.
11:06 p.m.
Everything about the deal suddenly made sense.
The late meeting.
The artificial urgency.
The carefully staged third-party verification.
Marcus did not want Donovan thinking overnight.
He wanted the money moved before anyone could examine the science independently.
“There isn’t another investor,” Clare said.
Marcus turned on her.
“You know nothing about this transaction.”
“I know pressure when I hear it.
If the technology is as strong as you claim, independent review wouldn’t threaten the deal.”
Donovan’s expression barely changed.
“She
